1 / 16

Immunizations and Immune Deficiency

Immunizations and Immune Deficiency. David B Nelson, MD MSc Professor and Chair Department of Pediatrics Georgetown University. Primary Inherited Usually single gene Various types B-lymphocytic T-lymphocytic Complement Phagocytic. Secondary (acquired) HIV/Aids Spenectomy

claire
Download Presentation

Immunizations and Immune Deficiency

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Immunizations and Immune Deficiency David B Nelson, MD MSc Professor and Chair Department of Pediatrics Georgetown University

  2. Primary Inherited Usually single gene Various types B-lymphocytic T-lymphocytic Complement Phagocytic Secondary (acquired) HIV/Aids Spenectomy Malignant neoplasms Transplant Autoimmune disease Immune suppressive therapy Severe malnutrition Types of Immune Suppression

  3. Killed and Inactive DPT HIB IPV Pneumococcal Polysaccharide Conjugated Injected influenza Hepatitis A Hepatitis B Meningococcal Polysaccharide Conjugated Typhoid Live Measles Mumps Rubella Rotavirus Intranasal influenza Varicella Oral polio BCG Typhoid Yellow Fever Vaccinia Vaccines

  4. Risk from Immunization in Immune Compromised Children • Limited data available for malignancy • Risk of adverse events in largely unknown • Data from HIV/AIDS • Relatively low risk of adverse reactions • When CD4 counts >15%

  5. Live Vaccines • Both bacterial and viral • Contraindicated in severe immune deficiency • Make cause severe disease • Generally not effective • Benefit may outweigh risk in less than severe immune deficiency

  6. Inactivated Vaccines • Use on schedule for immunecompromised • Risk of complications not increased • Immune response to vaccines may be poor • Secondary immune suppression • Key period is immune suppression within two weeks of immunization • After discontinuation of suppressive therapy normal response to vaccines in 3 to 12 months • Immune globulin should be given as appropriate • Measles prophylaxis should be given on exposure • Varicella—VZIG should be considered if available • Standard Hepatitis B, TIG, and HRIG indications

  7. Influenza Vaccine • Should be given every year prior to influenza season for both primary and secondary immune deficiency • Age 6 months and older • Use inactivated vaccine only • Give no sooner than 3-4 weeks after end of a course of chemotherapy • Peripheral granulocyte and lymphocyte counts >1000 cells/l

  8. Secondary (Acquired) Immunodeficiencies-HIV • BCG • Not recommended by WHO • Complications have been reported • Measles • Mortality as high as 40% • Do not need to test asymptomatic children • OK if CD4+ counts ≥ 15% • Give at 12 months and as soon as 28 days following first dose • Give at 6 months if outbreak • Varicella • Consider if CD4+ counts ≥ 15% • Inactivated vaccines should all be given according to the usual schedule • Passive immunoprophylaxis or chemoprophylaxis recommended even when vaccinated

  9. Secondary Immunodeficiency-Cancer • If possible vaccinate prior to chemotherapy • Two weeks prior to initiation of therapy • Live vaccines are contraindicated • Minimum of three months after therapy is ended • Inactivated vaccines should be given according to schedule • Give during maintenance therapy with ANC and ALC>1000cells/l • Test 4-6 weeks following vaccination if available • Retest at one year after therapy discontinued or revaccinate with a booster • Consider delaying vaccine for three months if coming of therapy • Children at increased risk from these diseases • Vaccinate close contacts

  10. Household Contacts • Smallpox and OPV contraindicated inhousehold contacts • MMR, varicella, rotavirus are OK in household contacts • Very low transmission rates • If rash with varicella, separate from patient • VZIG not indicated • Yearly inactivated influenza vaccination • Appropriate inactivated vaccines

  11. Hematopoietic Stem Cell Recipients • May retain donor immunity • Donor immunity for inactivated vaccines • Vaccinate donor prior to transplant • Facilitated by immunization within five weeks of transplant for recipient • Studied for diphtheria and tetanus • Presumed similar for other inactivated vaccines • May test at 12 months to determine protection

  12. HSCT Recipients--Live Viral Vaccines • May consider response to DPT as indicator of recovered immune response • Measles--Two years post HSCT • Second dose after 28 days • Don’t give if chronic GVHD • Varicella--data limited • Contraindicated <24 months after HSCT • >24 months by research protocol only • Give VZIG if exposed

  13. HSCT Recipients--Inactive Vaccines • Influenza • May give >6 months but may not be effective until 12 months • Hepatitis B--limited data • Three doses starting at 12 months post HSCT • Doses at 12, 14 and 24 months • Follow-up serology • Polio • IPV starting at 12 months post HSCT • Doses at 12, 14 and 24 months • Hib and Pneumococcal Conjugate Vaccine • Start at 12 months post HSCT • Doses at 12, 14 and 24 months • Pneumococcal Polysaccaride • After 24 months, repeat in 12 months

  14. Solid Organ Transplant Recipients • Give vaccines at least one month prior to transplant • May give measles vaccine as early as 6 months of age • No live vaccines after transplant • Use after 6 months on minimal immune suppressive therapy is being studied • Household contacts should be immunized • No live polio vaccine • Killed vaccines OK • Best after six months

  15. Asplenia • High risk for: • Pneumococcal disease • HIB • Meningococcal disease • Vaccinate prior to surgery (14 days) • PVC 13 or polysaccharide vaccine • HIB conjugate • Tetravalent conjugated Meningococcal • As early as 2 years old

  16. All Health Care Workers Should be fully immunized for: Polio, Pertussis Measles, Mumps, Rubella Varicella, Influenza Hepatitis A and B Health Care Workers

More Related